Wearable Device to Assess Mobility After Anterior Iliac Grafting Covered With a Regional Block Technique Transversus Abdominis Plane Block

April 4, 2026 updated by: Abdalkahar Shawki, Ain Shams University

Wearable Device to Assess Mobility After Anterior Iliac Grafting Covered With a Regional Block Technique Transversus Abdominis Plane Block: Randomized Controlled Trial

This study aimed to assess the effect of adding regional technique transversus abdominis plane (TAP) block on postoperative mobilization following anterior iliac bone grafting.

Study Overview

Detailed Description

Bone grafting or bone harvesting is a procedure to augment deficient bone tissue and is widely used in a number of oral and maxillofacial procedures such as reconstructive surgical interventions.

The role of regional anaesthesia in the prevention of central sensitization occurs when an effective nociceptive regional block prevents pain signals from being conducted from the surgical site to the central nervous system, preventing the development of chronic pain and persistent postsurgical pain (PPP).

The transversus abdominis plane (TAP) block permits a sensory block of the lower 6 thoracic and L1 ventral rami. Imaging studies on cadavers and volunteers have demonstrated the spread of solution in a plane between both muscles, with a subsequent sensory blockade from T8 to L1.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11591
        • Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescent until age range above 13 years old to ensure cooperation during data collection and adults with requirement to anterior iliac crest bone grafting for intraoral grafting.
  • Having no tumour or trauma in the lower limbs or ilium
  • Having no any other neural or muscular disorder which may merge with gait disturbance
  • Having no cognitive deficiency which may prevent understanding and performing of the study protocol.

Exclusion Criteria:

  • Patients with rheumatic disorders, low back pain, prosthesis of the hip or knees or previous iliac crest surgery.
  • Medical exclusion criteria are severe bronchopulmonary disease and cardiac problems affecting exercise tolerance, blood-clotting impairment, known allergy to the trial drugs, abdominal wall infection, morbid obesity (˃38 kg/m2).
  • Reported allergy to any of the drugs used.
  • Failure to follow up the accelerometry-derived data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Group (A)
Patients with requirement to anterior iliac crest bone grafting for intraoral transplantation without intervention.
Experimental: Group (B)
Patients received the transversus abdominis plane block in-addition to the regular General Anaesthesia protocols.
Patients received the transversus abdominis plane block in-addition to the regular General Anaesthesia protocols

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Distance
Time Frame: Third week postoperatively
Difference in Distance in meters totally covered through one week preoperative and third week postoperative.
Third week postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of increase in Distance
Time Frame: Third week postoperatively
Rate of increase in Distance was recorded three weeks postoperative
Third week postoperatively
Rate of increase in number of steps
Time Frame: Third week postoperatively
Rate of increase in number of steps was recorded three weeks postoperative
Third week postoperatively
Time in minutes to start walking after full recovery
Time Frame: 12 hours postoperatively
Patient was encouraged directly through the first 12 hours postoperatively to walk supervised 20 steps corridor for the first time.
12 hours postoperatively
Need of using walking aid
Time Frame: Third week postoperatively
Need of using walking aid was recorded in the first three weeks postoperatively
Third week postoperatively
Time in hours to develop worst pain
Time Frame: 24 hours postoperatively
Time in hours to develop worst pain was recorded during rest and motion in the first 24 hours postoperative.
24 hours postoperatively
Duration of the bone harvesting procedure
Time Frame: Intraoperatively
Duration of the bone harvesting procedure was recorded from the incision until wound closure.
Intraoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

February 1, 2026

Study Completion (Actual)

February 1, 2026

Study Registration Dates

First Submitted

April 4, 2026

First Submitted That Met QC Criteria

April 4, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 4, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 04-02-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

After the end of study for one year.

IPD Sharing Access Criteria

The data will be available upon a reasonable request from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility

Clinical Trials on Transversus Abdominis Plane Block

Subscribe